Pocahontas Memorial Hospital | |
57 Duncan Rd Buckeye WV 24924-9044 | |
(304) 799-1075 | |
Not Available |
Full Name | Pocahontas Memorial Hospital |
---|---|
Speciality | Clinic/center - Mental Health (including Community Mental Health Center) |
Location | 57 Duncan Rd, Buckeye, West Virginia |
Authorized Official Name and Position | Shannon Ruth Starcher (PROVIDER ENROLLMENT) |
Authorized Official Contact | 3047997400 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Pocahontas Memorial Hospital 150 Duncan Rd Buckeye WV 24924-9037 Ph: (304) 799-7400 | Pocahontas Memorial Hospital 57 Duncan Rd Buckeye WV 24924-9044 Ph: (304) 799-1075 |
NPI Number | 1821621632 |
---|---|
Provider Enumeration Date | 02/20/2020 |
Last Update Date | 02/20/2020 |
Certification Date | 02/20/2020 |
Identifier | Type | State | Issuer |
---|---|---|---|
1821621632 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
News Archive
The Assisted Living Federation of America, today hosted a meeting of 140 executives interested in advancing excellence in senior living. The day-long event at National Harbor, Maryland offered executives briefings on topics shaping their businesses today and peer discussions groups to help find answers to some of the big shared questions on their minds.
Although the government releases a list of what hospitals across the country charge for common procedures in an effort to make health costs more transparent, few patients or their insurers pay that.
Air Techniques, Inc., a leading dental equipment manufacturer, announced today that its STS-6 Dual Stage Dry Vacuum System was named an "Editor's Choice" by The Dental Advisor. The highly regarded science-based publication gave the STS-6 system the maximum possible overall rating of 5 stars as well as a 98% clinical rating.
Taking the breast cancer drug anastrozole for five years reduced the chances of post-menopausal women at high risk of breast cancer developing the disease by 53% compared with women who took a placebo, according to a study published in the Lancet today.
› Verified 4 days ago